The U.S. spends heavily to train and employ physicians, and patients place enormous trust in them.
Yet, across markets, patients with the same condition can receive very different treatments.
Why do highly skilled professionals make such different choices?
And what does that mean for costs, quality, and equity?
But physicians have an outsized role, shaping nearly all areas of delivery.
These affiliations influence autonomy, resources, and incentives.
Ownership affects institutional priorities and the constraints physicians face.
Variation raises the question: When is it waste?
Examples
- Payment quirks by location
- Advanced imaging with little benefit
- Proton therapy for some cancers
- Coronary stents for low-risk patients
- Arthroscopic knee surgery
But: waste is hard to identify prospectively.
See MIT report on end-of-life spending.